or Try an Advanced Search...

    Technical Analysis for ADXN - Addex Therapeutics Ltd

    Grade Last Price % Change Price Change
    F 7.38 -7.40% -0.59
    ADXN closed down 7.4 percent on Wednesday, November 20, 2024, on 27 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ADXN trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Calm After Storm Range Contraction -7.40%
    NR7 Range Contraction -7.40%
    Lower Bollinger Band Walk Weakness -7.40%
    Wide Bands Range Expansion -7.40%
    Oversold Stochastic Weakness -7.40%
    Stochastic Buy Signal Bullish -6.70%
    Calm After Storm Range Contraction -6.70%
    Older End-of-Day Signals for ADXN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Down 5% about 19 hours ago
    Down 3% about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    Down 2 % about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADXN Chart by TradingView
    Basic chart:

    Profile

    Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Neurological Disorders Urological Disorders Proteins Small Molecule Allosteric Regulation

    Is ADXN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 11 Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
    Sep 30 Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript
    Sep 30 Addex Therapeutics GAAP EPS of CHF0.08, revenue of CHF0.12M
    Sep 30 Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update
    Sep 19 Addex Therapeutics reports H1 results
    Sep 19 Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit
    Sep 4 Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 27 Addex stock rallies 45% on Indivior collaboration update
    Aug 27 Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
    Aug 27 Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration
    See more ADXN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.9
    52 Week Low 5.04
    Average Volume 40,408
    200-Day Moving Average 10.48
    50-Day Moving Average 9.95
    20-Day Moving Average 9.86
    10-Day Moving Average 8.89
    Average True Range 0.94
    RSI (14) 28.06
    ADX 18.19
    +DI 15.10
    -DI 29.70
    Chandelier Exit (Long, 3 ATRs) 9.02
    Chandelier Exit (Short, 3 ATRs) 10.15
    Upper Bollinger Bands 12.52
    Lower Bollinger Band 7.19
    Percent B (%b) 0.04
    BandWidth 54.05
    MACD Line -0.67
    MACD Signal Line -0.32
    MACD Histogram -0.3505
    Fundamentals Value
    Market Cap 7.82 Million
    Num Shares 1.06 Million
    EPS -20.60
    Price-to-Earnings (P/E) Ratio -0.36
    Price-to-Sales 5.24
    Price-to-Book 2.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.12
    Resistance 3 (R3) 8.18 8.00 7.99
    Resistance 2 (R2) 8.00 7.81 7.97 7.95
    Resistance 1 (R1) 7.69 7.70 7.60 7.63 7.91
    Pivot Point 7.51 7.51 7.47 7.48 7.51
    Support 1 (S1) 7.20 7.32 7.11 7.14 6.85
    Support 2 (S2) 7.02 7.21 6.99 6.81
    Support 3 (S3) 6.71 7.02 6.77
    Support 4 (S4) 6.65